SKIN Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03

Price $0.63

Market Cap (MRQ) $82M

P/E (TTM) -3.5

EPS (TTM) $-0.18

Revenue (TTM) $290M

ROE (TTM) -43.9%

52W Range $1–$2

SKIN Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04

range

bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

10-Year Performance Revenue, net income, margins and EPS trends

06

Revenue$301M

2019-12-31 → 2025-12-31

EPS$-0.16

2019-12-31 → 2025-12-31

Free Cash Flow$37M

2022-12-31 → 2025-12-31

Net margin-9.8%

2022-12-31 → 2025-12-31

Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric	SKIN	5Y avg	Peer Median	Verdict
P/E (TTM)	-3.55Y avg ≈-12.7	≈-12.7	·	·
P/S (TTM)	0.35Y avg ≈1.4	≈1.4	1.0	Undervalued
P/B (MRQ)	1.55Y avg ≈5.0	≈5.0	2.3	Undervalued
Price / FCF (TTM)	3.95Y avg ≈7.2	≈7.2	·	·
Price / Cash Flow (TTM)	3.75Y avg ≈5.8	≈5.8	14.7	Undervalued
Price / Tangible Book (MRQ)	3.2	·	·	·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric	SKIN	5Y avg	Peer Median	Verdict
Gross Margin (TTM)	66.4%5Y avg ≈56.8%	≈56.8%	69.2%	In line
Operating Margin (TTM)	-1.5%5Y avg ≈-16.7%	≈-16.7%	5.0%	In line
EBITDA Margin	-6.9%5Y avg ≈-16.7%	≈-16.7%	5.0%	In line
Pretax Margin (TTM)	-8.2%5Y avg ≈-6.0%	≈-6.0%	3.3%	Weak
Net Profit Margin (TTM)	-9.8%5Y avg ≈-6.2%	≈-6.2%	2.8%	Weak
ROA (TTM)	-5.7%5Y avg ≈-2.9%	≈-2.9%	5.6%	Weak
ROE (TTM)	-43.9%5Y avg ≈-44.8%	≈-44.8%	15.0%	Weak
ROIC	-54.6%5Y avg ≈-103.5%	≈-103.5%	14.5%	Weak

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric	5Y trend	SKIN	5Y avg	Peer Median	Verdict
Current Ratio (MRQ)		1.85Y avg ≈6.4	≈6.4	1.8	In line
Quick Ratio		0.15Y avg ≈3.6	≈3.6	0.4	Low liquidity

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric	SKIN	5Y avg	Peer Median	Verdict
Revenue YoY	-10.0%5Y avg ≈28.4%	≈28.4%	·	·
Revenue CAGR 3Y	-6.3%5Y avg ≈17.3%	≈17.3%	·	·
Revenue CAGR 5Y	20.4%	·	·	·

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric	SKIN	5Y avg	Peer Median	Verdict
EPS (Diluted)	$-0.165Y avg ≈$-1.04	≈$-1.04	·	·
Revenue / Share	$2.215Y avg ≈$2.51	≈$2.51	·	·
Cash Flow / Share	$0.285Y avg ≈$-0.04	≈$-0.04	·	·

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric	SKIN	5Y avg	Peer Median	Verdict
Asset Turnover	0.55Y avg ≈0.4	≈0.4	0.8	Weak
Inventory Turnover	1.85Y avg ≈1.9	≈1.9	3.5	Weak
Receivables Turnover	12.25Y avg ≈8.1	≈8.1	13.9	In line
Revenue / Employee	≈$490.7K	·	·	·

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14

Avg Surprise 34.1%

Next Report Nov 04, 2026

Period	Report	EPS Actual	EPS Est	Surprise
June 30, 2026	Aug 11, 2026	$-0.02	$-0.02	19.4%
March 31, 2026	May 7, 2026	$-0.05	$-0.08	36.5%
Dec. 31, 2025		$-0.06	$-0.05	-14.3%
Sept. 30, 2025		$-0.09	$-0.07	-30.2%
June 30, 2025		$0.03	$-0.05	155.7%
March 31, 2025		$-0.08	$-0.13	37.9%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15

Income Statement 18

Metric	2025	2024	2023	2022	2021	2020	2019
Revenue	$301M	$334M	$398M	$366M	$260M	$119M	$167M
Cost of Revenue	$104M	$152M	$243M	$117M	$82M	$52M	$60M
Gross Profit	$196M	$182M	$155M	$249M	$179M	$67M	$107M
R&D Expense	$6M	$6M	$10M	$8M	$8M	$3M	$5M
SG&A Expense	$118M	$125M	$131M	$106M	$99M	$31M	$27M
Operating Expenses	$217M	$250M	$286M	$275M	$218M	$84M	$93M
Operating Income	$-21M	$-68M	$-131M	$-26M	$-40M	$-17M	$13M
Interest Expense	·	·	$14M	$13M	$12M	·	·
Interest Income	$9M	$17M	$23M	$9M	$39.0K	·	·
Other Non-op	$19M	$34M	$5M	$-2M	$-4M	$-47.0K	$535.0K
Pretax Income	$-6M	$-30M	$-102M	$45M	$-381M	$-38M	$-3M
Income Tax	$4M	$-452.0K	$-2M	$1M	$-2M	$-9M	$-1M
Net Income	$-10M	$-29M	$-100M	$44M	$-379M	$-29M	$-2M
EPS (Basic)	$-0.08	$-0.23	$-0.76	$0.30	$-3.71	$-0.85	$-0.05
EPS (Diluted)	$-0.16	$-0.36	$-0.76	$-0.23	$-3.71	$-0.85	$-0.05
Shares (Basic)	126,378,509	123,827,372	131,680,605	147,554,090	102,114,949	34,293,271	32,136,203
Shares (Diluted)	135,798,202	142,492,575	131,680,605	148,506,312	102,114,949	34,293,271	32,136,203
EBITDA	$-21M	$-68M	$-131M	$-24M	·	·	·

Balance Sheet 26

Metric	2025	2024	2023	2022	2021	2020	2019
Cash & Equivalents	·	·	$523M	$568M	$902M	$9M	·
Receivables	$22M	$28M	$55M	$76M	$47M	$19M	·
Inventory	$48M	$69M	$91M	$110M	$35M	$23M	·
Prepaid Expense	$5M	$9M	$29M	$28M	$12M	$3M	·
Current Assets	$310M	$477M	$698M	$783M	$1.00B	$59M	·
PP&E (Net)	·	·	·	·	·	$9M	·
Accum. Depreciation	·	·	·	·	·	$4M	·
Goodwill	$127M	$123M	$126M	$125M	$124M	$99M	$99M
Intangibles	$36M	$48M	$62M	$46M	$56M	$51M	·
Other Non-current Assets	$12M	$14M	$16M	$14M	$7M	$5M	·
Total Assets	$500M	$686M	$929M	$1.00B	$1.22B	$223M	·
Accounts Payable	$16M	$22M	$45M	$28M	$29M	$18M	·
Accrued Liabilities	$15M	$20M	$20M	$15M	$15M	$2M	·
Current Liabilities	$186M	$68M	$115M	$72M	$76M	$31M	·
Capital Leases	$9M	$11M	$9M	$13M	$13M	$0	·
Deferred Tax	$393.0K	$396.0K	$702.0K	$2M	$4M	$4M	·
Other Non-current Liabilities	$2M	$2M	$3M	$0	$0	$2M	·
Total Liabilities	$439M	$634M	$870M	$836M	$917M	$253M	·
Long-term Debt	·	$552M	·	·	·	·	·
Common Stock	$13.0K	$12.0K	$12.0K	$14.0K	$16.0K	$4.0K	·
Paid-in Capital	$580M	$567M	$541M	$550M	$722M	$14M	·
Retained Earnings	$-517M	$-508M	$-479M	$-379M	$-419M	$-44M	·
AOCI	$-1M	$-7M	$-3M	$-5M	$-1M	$242.0K	·
Stockholders' Equity	$61M	$52M	$59M	$167M	$298M	$-31M	$-1M
Liabilities + Equity	$500M	$686M	$929M	$1.00B	$1.22B	$223M	·
Shares Outstanding	127,520,823	124,924,185	122,899,002	132,214,695	150,598,047	35,501,743	32,136,203

Cash Flow 13

Metric	2025	2024	2023	2022	2021	2020	2019
Stock-based Comp	$15M	$27M	$23M	$28M	$12M	$363.0K	$103.0K
Deferred Tax	$2M	$-4M	$-6M	$-2M	$-3M	$-4M	$-5M
Amort. of Intangibles	$17M	$20M	$21M	$15M	$13M	$12M	$13M
Restructuring	·	·	$7M	·	·	·	·
Operating Cash Flow	$37M	$16M	$22M	$-107M	$-28M	$-12M	$2M
CapEx	$303.0K	$756.0K	$4M	$11M	$11M	$4M	$9M
Investing Cash Flow	$-5M	$-7M	$-32M	$-19M	$-38M	$-4M	$-12M
Stock Repurchased	$0	$0	$30M	$160M	$0	$154.0K	$0
Net Stock Activity	$0	$0	$-30M	$-160M	·	·	·
Financing Cash Flow	$-175M	$-158M	$-37M	$-205M	$959M	$18M	$15M
Taxes Paid	$4M	$3M	$2M	$-1M	$2M	$2M	$861.0K
Free Cash Flow	$37M	$15M	$18M	$-117M	·	·	·
Levered FCF	·	·	$5M	·	·	·	·

Profitability 8

Metric	2025	2024	2023	2022	2021	2020	2019
Gross Margin	65.3%	54.5%	39.0%	68.4%	·	·	·
Operating Margin	-6.9%	-20.3%	-32.9%	-6.6%	·	·	·
Net Margin	-3.2%	-8.7%	-25.2%	12.1%	·	·	·
Pretax Margin	-2.0%	-8.8%	-25.6%	12.3%	·	·	·
EBITDA Margin	-6.9%	-20.3%	-32.9%	-6.6%	·	·	·
ROA	-1.6%	-3.6%	-10.4%	4.0%	·	·	·
ROE	-14.1%	-52.2%	-134.1%	21.0%	·	·	·
ROIC	-54.6%	-128.8%	-216.6%	-14.0%	·	·	·

Liquidity & Solvency 3

Metric	2025	2024	2023	2022	2021	2020	2019
Current Ratio	1.7	7.0	6.1	10.8	·	5.1	·
Quick Ratio	0.1	0.4	5.0	8.8	·	4.3	·
Interest Coverage	·	·	-9.6	·	·	·	·

Efficiency 3

Metric	2025	2024	2023	2022	2021	2020	2019
Asset Turnover	0.5	0.4	0.4	0.3	·	·	·
Inventory Turnover	1.8	1.9	2.4	1.5	·	·	·
Receivables Turnover	12.2	8.1	6.1	5.9	·	·	·

Per Share 5

Metric	2025	2024	2023	2022	2021	2020	2019
Book Value / Share	$0.48	$0.41	$0.48	$1.30	·	·	·
Revenue / Share	$2.21	$2.35	$3.02	$2.46	·	·	·
Cash Flow / Share	$0.28	$0.11	$0.17	$-0.72	·	·	·
Cash / Share	·	·	$4.26	$4.30	·	·	·
EPS (TTM)	$-0.16	$-0.36	$-0.76	$-0.23	$-3.71	$-0.85	·

Growth Rates 3

Metric	2025	2024	2023	2022	2021	2020	2019
Revenue YoY	-10.0%	-16.0%	8.8%	40.7%	118.4%	·	·
Revenue CAGR 3Y	-6.3%	8.7%	49.5%	·	·	·	·
Revenue CAGR 5Y	20.4%	·	·	·	·	·	·

Valuation (TTM) 10

Metric	2025	2024	2023	2022	2021	2020	2019
Revenue TTM	$301M	$334M	$398M	$366M	$260M	$119M	·
Net Income TTM	$-10M	$-29M	$-100M	$44M	$-379M	$-29M	·
Market Cap	$177M	$199M	$382M	$1.20B	·	·	·
P/E	-8.7	-4.4	-4.1	-39.6	-6.5	-13.3	·
P/S	0.6	0.6	1.0	3.3	·	·	·
P/B	2.9	3.8	6.4	7.0	·	·	·
P / Tangible Book	·	·	·	·	30.7	·	·
P / Cash Flow	4.7	12.3	17.6	-11.3	·	·	·
P / FCF	4.8	12.9	21.3	-10.2	·	·	·
Earnings Yield	-11.5%	-22.6%	-24.4%	-2.5%	-15.4%	-7.5%	·

Income Statement 18

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$72M	$65M	$82M	$71M	$78M	$70M	$83M	$79M	$91M	$81M	$97M	$97M	$117M	$86M	$98M	$89M
Cost of Revenue	$23M	$20M	$29M	$25M	$29M	$21M	$31M	$38M	$50M	$33M	$51M	$110M	$50M	$32M	$32M	$27M
Gross Profit	$49M	$44M	$53M	$46M	$49M	$49M	$52M	$41M	$41M	$48M	$46M	$-13M	$68M	$54M	$66M	$61M
R&D Expense	$1M	$1M	$2M	$2M	$1M	$998.0K	$1M	$1M	$1M	$3M	$3M	$2M	$3M	$2M	$1M	$2M
SG&A Expense	$23M	$22M	$28M	$29M	$27M	$34M	$32M	$33M	$31M	$29M	$29M	$37M	$35M	$30M	$28M	$24M
Operating Expenses	$46M	$46M	$53M	$52M	$52M	$61M	$60M	$62M	$63M	$65M	$64M	$70M	$81M	$71M	$69M	$66M
Operating Income	$4M	$-2M	$162.0K	$-6M	$-3M	$-12M	$-7M	$-22M	$-22M	$-17M	$-18M	$-82M	$-13M	$-17M	$-2M	$-4M
Interest Expense	·	·	·	·	·	·	·	·	·	$3M	·	$3M	$3M	$3M	·	$3M
Interest Income	$1M	$1M	$2M	$1M	$3M	$3M	$2M	$5M	$4M	$5M	$6M	$7M	$6M	$4M	$6M	$3M
Other Non-op	$19.0K	$1M	$124.0K	$601.0K	$18M	$60.0K	$88.0K	$69.0K	$17M	$16M	$-137.0K	$5M	$47.0K	$418.0K	$-1M	$-361.0K
Pretax Income	$-1M	$-7M	$-5M	$-11M	$19M	$-9M	$-12M	$-16M	$-151.0K	$-1M	$-9M	$-70M	$1M	$-24M	$6M	$-902.0K
Income Tax	$1M	$-184.0K	$3M	$386.0K	$-993.0K	$892.0K	$-1M	$2M	$-353.0K	$-659.0K	$603.0K	$3M	$-2M	$-4M	$-755.0K	$-821.0K
Net Income	$-3M	$-7M	$-8M	$-11M	$20M	$-10M	$-10M	$-18M	$202.0K	$-679.0K	$-9M	$-74M	$3M	$-20M	$7M	$-81.0K
EPS (Basic)	$-0.02	$-0.05	$-0.07	$-0.09	$0.16	$-0.08	$-0.07	$-0.15	$0.00	$-0.01	$-0.08	$-0.56	$0.03	$-0.15	$0.05	$0.00
EPS (Diluted)	$-0.02	$-0.05	$-0.02	$-0.09	$0.03	$-0.08	$-0.01	$-0.15	$-0.10	$-0.10	$-0.08	$-0.56	$0.03	$-0.15	$-0.01	$-0.03
Shares (Basic)	129,596,886	127,792,611	·	126,890,888	126,072,603	125,079,470	·	124,057,602	123,718,797	123,120,426	·	132,896,626	132,716,024	132,420,762	·	150,788,695
Shares (Diluted)	129,596,886	131,399,898	·	126,890,888	140,294,291	125,079,470	·	124,057,602	141,927,750	144,477,208	·	132,896,626	132,716,024	132,420,762	·	151,417,710
EBITDA	$4M	$-2M	·	$-6M	$-3M	$-12M	·	$-22M	$-22M	$-17M	·	$-82M	$-13M	$-17M	·	·

Balance Sheet 24

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	·	·	·	·	·	·	·	·	·	·	·	$559M	$550M	$532M	·	$684M
Receivables	$18M	$19M	$22M	$22M	$25M	$23M	$28M	$36M	$41M	$48M	·	$67M	$75M	$71M	·	$84M
Inventory	$47M	$48M	$48M	$56M	$59M	$66M	$69M	$73M	$77M	$96M	·	$75M	$107M	$122M	·	$102M
Prepaid Expense	$23M	$5M	$5M	$7M	$8M	$7M	$9M	$16M	$21M	$26M	·	$36M	$31M	$22M	·	$22M
Current Assets	$295M	$278M	$310M	$308M	$306M	$469M	$477M	$485M	$490M	$615M	·	$738M	$768M	$749M	·	$892M
Goodwill	$126M	$126M	$127M	$126M	$126M	$124M	$123M	$125M	$125M	$125M	$126M	$125M	$125M	$125M	·	$123M
Intangibles	$30M	$33M	$36M	$38M	$43M	$46M	$48M	$51M	$54M	$58M	·	$65M	$66M	$71M	·	$47M
Other Non-current Assets	$11M	$11M	$12M	$13M	$13M	$14M	$14M	$15M	$16M	$16M	·	$16M	$16M	$16M	·	$10M
Total Assets	$487M	$473M	$500M	$504M	$508M	$674M	$686M	$700M	$712M	$845M	·	$973M	$1.01B	$995M	·	$1.10B
Accounts Payable	$16M	$16M	$16M	$17M	$23M	$23M	$22M	$23M	$27M	$37M	·	$36M	$29M	$34M	·	$33M
Accrued Liabilities	$32M	$19M	$15M	$19M	$14M	$17M	$20M	$28M	$24M	$24M	·	$30M	$19M	$13M	·	$17M
Current Liabilities	$168M	$155M	$186M	$62M	$59M	$63M	$68M	$74M	$75M	$94M	·	$126M	$83M	$72M	·	$76M
Capital Leases	$18M	$19M	$9M	$11M	$8M	$10M	$11M	$12M	$13M	$14M	·	$10M	$11M	$12M	·	$11M
Deferred Tax	$393.0K	$393.0K	$393.0K	$112.0K	$217.0K	$402.0K	$396.0K	$1M	$1M	$1M	·	$2M	$2M	$3M	·	$4M
Other Non-current Liabilities	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$699.0K	$2M	$3M	·	$410.0K	$979.0K	·	·	·
Total Liabilities	$431M	$418M	$439M	$438M	$434M	$628M	$634M	$640M	$643M	$781M	·	$883M	$846M	$847M	·	$847M
Long-term Debt	·	·	·	$363M	$363M	·	·	·	·	·	·	·	·	·	·	·
Common Stock	$13.0K	$13.0K	$13.0K	$13.0K	$13.0K	$13.0K	$12.0K	$12.0K	$12.0K	$12.0K	·	$14.0K	$14.0K	$14.0K	·	$15.0K
Paid-in Capital	$584M	$581M	$580M	$577M	$575M	$570M	$567M	$561M	$553M	$547M	·	$565M	$561M	$555M	·	$643M
Retained Earnings	$-527M	$-524M	$-517M	$-509M	$-498M	$-518M	$-508M	$-498M	$-479M	$-480M	·	$-469M	$-396M	$-404M	·	$-378M
AOCI	$-1M	$-2M	$-1M	$-2M	$-2M	$-6M	$-7M	$-4M	$-5M	$-4M	·	$-5M	$-4M	$-4M	·	$-7M
Stockholders' Equity	$56M	$55M	$61M	$66M	$74M	$46M	$52M	$60M	$69M	$63M	$59M	$90M	$162M	$148M	$167M	$258M
Liabilities + Equity	$487M	$473M	$500M	$504M	$508M	$674M	$686M	$700M	$712M	$845M	·	$973M	$1.01B	$995M	·	$1.10B
Shares Outstanding	130,104,671	129,144,801	127,520,823	127,301,264	126,764,562	125,246,286	124,924,185	124,111,434	123,993,785	123,453,419	122,899,002	132,569,193	132,881,417	132,626,954	132,214,695	143,201,041

Cash Flow 12

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Stock-based Comp	$3M	$2M	$4M	$2M	$5M	$3M	$6M	$8M	$6M	$7M	$2M	$8M	$9M	$4M	$8M	$7M
Deferred Tax	·	·	·	·	·	·	$-3M	$2M	$-1M	$-1M	$-6M	$333.0K	$279.0K	$-279.0K	$-2M	$32.0K
Amort. of Intangibles	$4M	$4M	$3M	$7M	$4M	$3M	$4M	$5M	$5M	$5M	$5M	$5M	$7M	$4M	$4M	$5M
Restructuring	·	·	·	·	·	·	·	·	·	·	·	$600.0K	·	·	·	·
Operating Cash Flow	$3M	$-6M	$15M	$10M	$10M	$3M	$16M	$10M	$6M	$-17M	$-5M	$18M	$22M	$-13M	$-5M	$-31M
CapEx	$427.0K	$224.0K	$139.0K	$27.0K	$92.0K	$45.0K	$74.0K	$4.0K	$334.0K	$344.0K	$28.0K	$174.0K	$1M	$2M	$967.0K	$4M
Investing Cash Flow	$-1M	$-2M	$-1M	$-1M	$-2M	$-1M	$-862.0K	$-2M	$-2M	$-2M	$-2M	$-4M	$-3M	$-22M	$-3M	$-8M
Stock Repurchased	·	·	·	·	·	·	·	·	·	·	$30M	·	·	·	$80M	·
Financing Cash Flow	$-224.0K	$-21M	$-512.0K	$-803.0K	$-173M	$-250.0K	$-770.0K	$-204.0K	$-99M	$-59M	$-31M	$-2M	$-2M	$-2M	$-102M	$-100M
Taxes Paid	·	·	·	·	·	·	·	·	·	·	·	·	·	·	$670.0K	$-5M
Free Cash Flow	·	$-6M	·	·	·	$3M	·	·	·	$-17M	·	·	·	$-15M	·	·
Levered FCF	·	·	·	·	·	·	·	·	·	$-19M	·	·	·	$-18M	·	·

Profitability 8

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Gross Margin	68.4%	68.5%	·	64.6%	62.8%	69.8%	·	51.6%	45.2%	59.4%	·	-12.9%	57.8%	62.7%	·	·
Operating Margin	5.0%	-2.8%	·	-8.8%	-3.5%	-17.3%	·	-27.3%	-24.4%	-20.9%	·	-84.3%	-11.2%	-20.1%	·	·
Net Margin	-3.7%	-10.2%	·	-15.6%	25.2%	-14.5%	·	-23.2%	0.22%	-0.83%	·	-75.8%	2.9%	-25.8%	·	·
Pretax Margin	-2.0%	-10.5%	·	-15.1%	23.9%	-13.2%	·	-20.7%	-0.17%	-1.6%	·	-72.2%	1.0%	-30.1%	·	·
EBITDA Margin	5.0%	-2.8%	·	-8.8%	-3.5%	-17.3%	·	-27.3%	-24.4%	-20.9%	·	-84.3%	-11.2%	-20.1%	·	·
ROA	-0.54%	-1.2%	·	-1.8%	3.2%	-1.3%	·	-2.2%	0.02%	-0.07%	·	-7.1%	0.30%	-2.0%	·	·
ROE	-4.1%	-13.1%	·	-17.6%	27.5%	-18.5%	·	-24.4%	0.17%	-0.64%	·	-42.4%	1.3%	-9.1%	·	·
ROIC	11.7%	-3.2%	·	-9.8%	-3.8%	-28.6%	·	-40.3%	42.8%	-13.6%	·	-95.8%	-23.3%	-10.1%	·	·

Liquidity & Solvency 3

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	1.8	1.8	·	5.0	5.1	7.5	·	6.6	6.5	6.6	·	5.9	9.3	10.3	·	·
Quick Ratio	0.1	0.1	·	0.4	0.4	0.4	·	0.5	0.5	0.5	·	5.0	7.5	8.3	·	·
Interest Coverage	·	·	·	·	·	·	·	·	·	-5.6	·	-23.8	-3.8	-5.1	·	·

Efficiency 3

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	·
Inventory Turnover	0.4	0.4	·	0.4	0.4	0.3	·	0.5	0.5	0.3	·	1.2	0.5	0.4	·	·
Receivables Turnover	3.4	3.1	·	2.4	2.4	2.0	·	1.5	1.6	1.4	·	1.3	1.5	1.3	·	·

Per Share 5

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$0.43	$0.43	·	$0.52	$0.58	$0.37	·	$0.48	$0.56	$0.51	·	$0.68	$1.22	$1.11	·	·
Revenue / Share	$0.56	$0.49	·	$0.56	$0.56	$0.56	·	$0.64	$0.64	$0.56	·	$0.73	$0.89	$0.65	·	·
Cash Flow / Share	·	$-0.04	·	·	·	$0.02	·	·	·	$-0.12	·	·	·	$-0.10	·	·
Cash / Share	·	·	·	·	·	·	·	·	·	·	·	$4.22	$4.14	$4.01	·	·
EPS (TTM)	$-0.18	$-0.13	·	$-0.15	$-0.21	$-0.34	·	$-0.43	$-0.84	$-0.71	·	$-0.69	$-0.16	$-0.25	·	$-1.85

Valuation (TTM) 9

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$290M	$296M	·	$302M	$310M	$322M	·	$348M	$366M	$393M	·	$399M	$391M	$377M	·	$336M
Net Income TTM	$-28M	$-6M	·	$-12M	$-19M	$-39M	·	$-28M	$-84M	$-81M	·	$-84M	$-10M	$-7M	·	$-177M
Market Cap	$90M	$115M	·	$253M	$242M	$168M	·	$179M	$238M	$548M	·	$798M	$1.11B	$1.68B	·	·
P/E	-3.9	-6.8	·	-13.3	-9.1	-3.9	·	-3.3	-2.3	-6.3	·	-8.7	-52.3	-50.5	·	-6.4
P/S	0.3	0.4	·	0.8	0.8	0.5	·	0.5	0.7	1.4	·	2.0	2.8	4.4	·	·
P/B	1.6	2.1	·	3.9	3.3	3.6	·	3.0	3.4	8.7	·	8.9	6.9	11.3	·	·
P / Tangible Book	·	·	·	·	·	·	·	·	·	·	·	·	·	·	·	19.1
P / Cash Flow	·	-20.7	·	·	·	56.0	·	·	·	-32.5	·	·	·	-128.8	·	·
Earnings Yield	-26.0%	-14.6%	·	-7.5%	-11.0%	-25.4%	·	-29.9%	-43.8%	-16.0%	·	-11.5%	-1.9%	-2.0%	·	-15.7%

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$301M	$334M	$398M	$366M	$260M
Gross Margin %	65.3%	54.5%	39.0%	68.4%	·
Operating Margin %	-6.9%	-20.3%	-32.9%	-6.6%	·
Net Income	$-10M	$-29M	$-100M	$44M	$-379M
Diluted EPS	$-0.16	$-0.36	$-0.76	$-0.23	$-3.71

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Current Ratio	1.7	7.0	6.1	10.8	·
Quick Ratio	0.1	0.4	5.0	8.8	·

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Free Cash Flow	$37M	$15M	$18M	$-117M	·

Institutional owners (13F) 104 filers · $56.8M total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 104

Value held $56.8M

New positions 13

Exited positions 31

Institutional activity — Q2 2026 vs prior quarter

New positions	Exited positions	Increased	Decreased	Net shares change
13 (-10 vs prior Q)	31 (+13 vs prior Q)	24 (-11 vs prior Q)	42 (+4 vs prior Q)	-11.3M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution	Value	Shares	% of tracked 13F	Type
Capricorn Fund Managers Ltd	$15,426,777	22,276,935	27.14%	Shares
VANGUARD GROUP INC	$7,876,411	5,666,483	13.86%	Shares
FMR LLC	$7,064,667	10,201,685	12.43%	Shares
BlackRock, Inc.	$5,897,471	8,516,203	10.38%	Shares
MILLENNIUM MANAGEMENT LLC	$5,219,330	7,536,938	9.18%	Shares
UBS Group AG	$2,454,720	3,542,164	4.32%	Call option
VANGUARD CAPITAL MANAGEMENT LLC	$2,423,064	3,496,485	4.26%	Shares
Woodline Partners LP	$1,612,625	2,328,700	2.84%	Shares
Silver Point Capital L.P.	$1,102,481	1,592,030	1.94%	Shares
D. E. Shaw & Co., Inc.	$991,876	1,432,312	1.75%	Shares
GEODE CAPITAL MANAGEMENT, LLC	$665,356	960,374	1.17%	Shares
UBS Group AG	$581,692	839,383	1.02%	Shares
Squarepoint Ops LLC	$466,613	673,809	0.82%	Shares
Glendon Capital Management LP	$441,091	636,954	0.78%	Shares
Prescott Group Capital Management, L.L.C.	$400,078	577,730	0.70%	Shares
VANGUARD FIDUCIARY TRUST CO	$344,598	497,255	0.61%	Shares
AQR CAPITAL MANAGEMENT LLC	$335,106	483,908	0.59%	Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$284,190	410,382	0.50%	Shares
GRIMES & Co WEALTH MANAGEMENT, LLC	$281,839	406,987	0.50%	Shares
STATE STREET CORP	$268,101	387,150	0.47%	Shares
RENAISSANCE TECHNOLOGIES LLC	$252,549	364,691	0.44%	Shares
JACOBS LEVY EQUITY MANAGEMENT, INC	$226,709	327,377	0.40%	Shares
TUDOR INVESTMENT CORP ET AL	$208,634	301,277	0.37%	Shares
XTX Topco Ltd	$206,310	297,921	0.36%	Shares
Cohen Capital Management, Inc.	$166,947	241,079	0.29%	Shares
NORTHERN TRUST CORP	$140,306	202,608	0.25%	Shares
MARSHALL WACE, LLP	$132,737	192,373	0.23%	Shares
CITADEL ADVISORS LLC	$117,933	170,300	0.21%	Shares
GOLDMAN SACHS GROUP INC	$83,810	121,025	0.15%	Shares
CDC Financial, Inc.	$82,408	119,000	0.14%	Shares
Cubist Systematic Strategies, LLC	$70,530	35,442	0.12%	Shares
Qube Research & Technologies Ltd	$60,908	87,954	0.11%	Shares
DIMENSIONAL FUND ADVISORS LP	$60,264	87,024	0.11%	Shares
Marex Group Ltd	$60,040	86,700	0.11%	Shares
KNIGHTSBRIDGE ASSET MANAGEMENT, LLC	$52,111	75,250	0.09%	Shares
BANK OF AMERICA CORP /DE/	$50,216	72,567	0.09%	Shares
Global Retirement Partners, LLC	$42,866	61,900	0.08%	Shares
Russell Investments Group, Ltd.	$40,198	58,050	0.07%	Shares
SCS Capital Management LLC	$34,625	50,000	0.06%	Shares
IEQ CAPITAL, LLC	$33,701	48,666	0.06%	Shares
JANE STREET GROUP, LLC	$33,586	48,500	0.06%	Call option
KESTRA PRIVATE WEALTH SERVICES, LLC	$32,894	47,500	0.06%	Shares
Point72 Asset Management, L.P.	$32,220	46,527	0.06%	Shares
CWM, LLC	$30,419	34,179	0.05%	Shares
FRANKLIN RESOURCES INC	$25,992	37,533	0.05%	Shares
MORGAN STANLEY	$25,498	36,821	0.04%	Shares
Graham Capital Management, L.P.	$24,301	35,092	0.04%	Shares
Vanguard Global Advisers, LLC	$23,378	33,734	0.04%	Shares
MTM Investment Management, LLC	$22,160	32,000	0.04%	Shares
Schonfeld Strategic Advisors LLC	$21,468	31,001	0.04%	Shares

Show all 104 institutional owners →

Activists & 5%+ owners 2 positions

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer	Filed	Stake	Status	Purpose	Filing
LCP Edge Holdco, LLC, Linden Capital III LLC, Linden Manager III LP, Linden Capital Partners III LP, Linden Capital Partners III-A LP, Anthony Davis, Brian Miller ×3 filings	May 11, 2026	25.74%	Amendment	·	SEC
LCP Edge Holdco LLC (2), Linden Capital III LLC (2), Linden Manager III LP (2), Linden Capital Partners III-A LP (2), Anthony Davis (2), Brian Miller (2) ×3 filings	July 19, 2021	·	Initial filing	·	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 21 insiders · 11 officers · 13 directors

19

Insider	Role	Last activity	Shares owned	Net 12m
Pedro Bruno Ferreira Malha	President and CEO	March 20, 2026 A	4,845,251	$0
Marla Malcolm Beck	President and CEO	April 9, 2025 F	2,753,401	$0
Andrew Roy Stanleick	Chief Executive Officer	Aug. 17, 2023 P	702,933	$0
Clinton E. Carnell	Chief Executive Officer	Sept. 10, 2021 A	2,470,174	$0
MONAHAN MICHAEL P.	Chief Financial Officer	Aug. 10, 2026 F	1,955,280	$0
Stephan Becker	President, EMEA	Feb. 4, 2022 A	55,596	$0
Indra Pamamull	President, APAC	Feb. 4, 2022 A	66,716	$0
Sheri Lewis	CSO and COO	April 9, 2026 F	1,584,620	$0
Bradley Hauser	Chief Operating Officer	Nov. 29, 2023 A	390,632	$0
Ronald Menezes	Chief Revenue Officer	March 20, 2026 A	1,759,915	$0
Daniel Copell Watson	Chief Revenue Oficer	April 5, 2024 F	778,112	$0
Philippe Schaison	Director	Nov. 13, 2025 A	57,692	$0
Brian Miller	Director	June 16, 2025 A	243,035	$0
Doug K. Schillinger	Director	June 16, 2025 A	216,035	$0
Desiree Gruber	Director	June 16, 2025 A	192,565	$0
Michelle C. Kerrick	Director	June 16, 2025 A	189,813	$0
Brent L Saunders	Director	June 16, 2025 A	5,994,820	$0
Stephen J Fanning	Director	June 16, 2025 A	527,283	$0
Julius Few	Director	July 8, 2024 A	194,341	$0
Michael D Capellas	Director	July 8, 2024 A	276,146	$0
Liyuan Woo	·	Aug. 10, 2023 A	591,388	$0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 2 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund	Weight	Units	As of	Source
VXF · VANGUARD INDEX FUNDS	0.00%	925,221 SH	Aug. 19, 2026	Daily
VTI · VANGUARD INDEX FUNDS	0.00%	2,483,652 SH	Aug. 19, 2026	Daily

SKIN Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21

rating · 14 analysts HOLD

Median target $0.95 +50.8%

0 0.0% Strong Buy

1 7.1% Buy

8 57.1% Hold

3 21.4% Sell

2 14.3% Strong Sell

12-Month Price Target

6 analysts · 2026-09-29

Mean target $0.99 +57.4%

← Below all targets Current price $0.63

Low$0.70 Mean$0.99 High$1.50

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker	Market Cap	P/E	Rev YoY	Net Margin	ROE	Gross Margin
SKIN	$177M	-8.7	-10.0%	-3.2%	-14.1%	65.3%
MED	$117M	-6.3	-36.0%	-4.8%	-9.0%	71.3%
UPXI	$62M	-0.2	58.1%	-984.3%	9654.9%	89.5%
FTLF	·	25.8	26.4%	·	·	·
LFVN	$78M	15.6	-20.1%	2.8%	15.2%	77.6%
UG	$28M	·	-13.4%	20.0%	18.6%	·
EL	·	157.9	5.1%	1.2%	4.8%	75.5%

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

SKIN Class A The Beauty Health Company - Class A Common Stock